Kevin D Colbert

US Patent:

20200069846, Mar 5, 2020

Filed:

Jul 18, 2019

Appl. No.:

16/515819

Inventors:

- Baltimore MD, US
Hai-Quan Mao - Baltimore MD, US
Sashank Reddy - Baltimore MD, US
Kevin Colbert - Baltimore MD, US

International Classification:

A61L 27/56
A61L 27/48
A61L 27/54

Abstract:

A composite material can include a gel and at least one nanostructure disposed within the gel. A method for healing a soft tissue defect can include applying a composite material to a soft tissue defect, wherein the composite material includes a gel and a nanostructure disposed within the gel. A method for manufacturing a composite material for use in healing soft tissue defects can include providing a gel and disposing nanofibers within the gel.

US Patent:

20200030496, Jan 30, 2020

Filed:

Jul 18, 2019

Appl. No.:

16/515946

Inventors:

- Baltimore MD, US
Russell Martin - Baltimore MD, US
Xiaowei Li - Towson MD, US
Calvin Chang - Baltimore MD, US
Kevin Colbert - Baltimore MD, US
Hai-Quan Mao - Baltimore MD, US

International Classification:

A61L 27/58
A61L 27/54
A61L 27/20
A61L 27/18
A61L 27/44
A61L 27/52
A61L 27/38
A61M 5/19

Abstract:

A soft tissue device can incorporate a composite material comprising a gel and at least one nanostructure disposed within the gel. A soft tissue device can further incorporate biologically active materials such as cells, tissues. A method for healing a soft tissue defect while promoting soft tissue regeneration can include applying a soft tissue device to a soft tissue defect, wherein the composite material includes a gel and a nanostructure disposed within the gel. A method for manufacturing a soft tissue device for use in healing soft tissue defects can include providing a gel, disposing nanofibers within the gel, and a biologically active material.

US Patent:

20180236127, Aug 23, 2018

Filed:

Apr 25, 2018

Appl. No.:

15/962911

Inventors:

- Baltimore MD, US
Pratik Patel - Baltimore MD, US
Kevin Colbert - Baltimore MD, US
Ashish Nimgaonkar - Baltimore MD, US
Pankaj Pasricha - Ellicott City MD, US

International Classification:

A61L 24/04
A61L 24/06
C08L 33/02
A61L 24/08
C08L 5/08
A61K 9/70

Abstract:

Devices for and methods of treatment of metabolic syndromes are disclosed. Namely, the presently disclosed devices and methods are provided for affecting the function of the gastrointestinal endocrine system in key regions of the gut, thereby, producing therapeutic effects on obesity, diabetes and other metabolic syndromes. In some embodiments, the devices include multilayered bioadhesive patches delivered orally by dissolvable ingestible capsule, wherein various mechanisms are provided for anchoring the bioadhesive patches to the duodenal mucosa.

US Patent:

20180228863, Aug 16, 2018

Filed:

Aug 5, 2016

Appl. No.:

15/750460

Inventors:

- Baltimore MD, US
Michael Parlato - Baltimore MD, US
Pratik Patel - Worcester MA, US
Kevin Colbert - Baltimore MD, US
Ashish Nimgaonkar - Baltimore MD, US
Pankaj Pasricha - Ellicott City MD, US

International Classification:

A61K 38/02
A61K 9/20
A61K 47/26
A61K 9/16
A61K 9/50

Abstract:

The present invention provides compositions and methods for treatment of metabolic syndromes. Namely, the presently disclosed compositions and methods are provided for affecting the function of the gastrointestinal endocrine system in key regions of the gut, thereby, producing therapeutic effects on obesity, diabetes and other metabolic disorders. The compositions include components for forming luminal barriers within the gastrointestinal tract of a subject where the barrier is created in-situ via interaction of resident mucin with the mucin-interacting agent.

US Patent:

20180116515, May 3, 2018

Filed:

Apr 15, 2016

Appl. No.:

15/566754

Inventors:

- Baltimore MD, US
Ashley Polhemus - Meford Lakes NJ, US
Kevin Colbert - Baltimore MD, US
Vaishakhi Mayya - Pennington NJ, US
Aaron Enten - Baltimore MD, US
Joshua Budman - Baltimore MD, US

International Classification:

A61B 5/00
G01N 33/49
A61B 5/1455

Abstract:

The present invention is directed to a bio-fluid detector such as a hemoglobin detector having the capability of receiving, storing and transmitting health information utilizing a portable transmitter and receiver including electronic PDAs such as cell phones. Further, the present invention utilizes a non-invasive hemoglobin detector that is connected to a portable transmitter-receiver such as PDAs including, but not limited to, cell phones.

US Patent:

20160354509, Dec 8, 2016

Filed:

Feb 10, 2015

Appl. No.:

15/117715

Inventors:

- Baltimore MD, US
Pratik Patel - Baltimore MD, US
Kevin Colbert - Baltimore MD, US
Ashish Nimgaonkar - Baltimore MD, US
Pankaj Pasricha - Ellicott City MD, US

International Classification:

A61L 24/04

Abstract:

Devices for and methods of treatment of metabolic syndromes are disclosed. Namely, the presently disclosed devices and methods are provided for affecting the function of the gastrointestinal endocrine system in key regions of the gut, thereby, producing therapeutic effects on obesity, diabetes and other metabolic syndromes. In some embodiments, the devices include multilayered bioadhesive patches delivered orally by dissolvable ingestible capsule, wherein various mechanisms are provided for anchoring the bioadhesive patches to the duodenal mucosa.